Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCNB1IP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | DNAJC4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | PIP5K1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | C14orf37 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | COPG2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | C14orf178 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ZBTB33 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | APLP1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | BIRC6 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | OR52W1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |